Town Hall Ventures and Foresite Capital led a $60m Series B round in Thyme Care, a provider of oncology care management solutions, with participation from Andreessen Horowitz, AlleyCorp, Casdin Capital, and Frist Cressey Ventures. "The best medicine in the world isn't effective if a patient can't afford treatment or get a ride to the office. That's a missed opportunity, and quite honestly it's inexcusable. Thyme Care is built on the belief that we must meaningfully change the standard of cancer care and eradicate the common barriers that exist today. Our latest investment validates our mission to transform cancer care and accelerate the move to value-based oncology care," Bobby Green, Thyme Care Co-founder, President and Chief Medical Officer.